Source link : https://www.newshealth.biz/health-news/can-ai-tool-guide-cdk4-6-inhibitor-use-in-breast-cancer/
SAN ANTONIO — A machine learning model, which incorporates both clinical and genomic factors, helps predict which patients with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) metastatic breast cancer will benefit from adding a CDK4/6 inhibitor to frontline endocrine therapy, according to new research. There is a huge need to identify patients who […]
Author : News Health
Publish date : 2024-12-19 12:04:03
Copyright for syndicated content belongs to the linked Source.
inHealth